These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Human eosinophil lysophospholipase: the sole protein component of Charcot-Leyden crystals. Weller PF; Bach D; Austen KF J Immunol; 1982 Mar; 128(3):1346-9. PubMed ID: 6173432 [TBL] [Abstract][Full Text] [Related]
23. Vesicular transport of peroxidase in human eosinophilic myelocytes. Dvorak AM; Estrella P; Ishizaka T Clin Exp Allergy; 1994 Jan; 24(1):10-8. PubMed ID: 8156439 [TBL] [Abstract][Full Text] [Related]
24. Human eosinophils in vitro. An ultrastructural morphology primer. Dvorak AM; Ishizaka T Histol Histopathol; 1994 Apr; 9(2):339-74. PubMed ID: 8075495 [TBL] [Abstract][Full Text] [Related]
25. Formation of Charcot-Leyden crystals by human basophils in sputum and peripheral blood. Tanabe K; Takahashi K; Maeda M; Kimura I Acta Med Okayama; 1993 Apr; 47(2):85-90. PubMed ID: 8506754 [TBL] [Abstract][Full Text] [Related]
26. Ultrastructural morphology of immature mast cells in sequential suspension cultures of human cord blood cells supplemented with c-kit ligand; distinction from mature basophilic leukocytes undergoing secretion in the same cultures. Dvorak AM; Mitsui H; Ishizaka T J Leukoc Biol; 1993 Nov; 54(5):465-85. PubMed ID: 7693841 [TBL] [Abstract][Full Text] [Related]
27. Evidence for secretion of human eosinophil granule major basic protein and Charcot-Leyden crystal protein during eosinophil maturation. Butterfield JH; Ackerman SJ; Scott RE; Pierre RV; Gleich GJ Exp Hematol; 1984 Mar; 12(3):163-70. PubMed ID: 6705849 [TBL] [Abstract][Full Text] [Related]
28. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. Ackerman SJ; Corrette SE; Rosenberg HF; Bennett JC; Mastrianni DM; Nicholson-Weller A; Weller PF; Chin DT; Tenen DG J Immunol; 1993 Jan; 150(2):456-68. PubMed ID: 8419478 [TBL] [Abstract][Full Text] [Related]
29. The Charcot-Leyden crystal protein revisited-A lysopalmitoylphospholipase and more. Weller PF; Wang H; Melo RCN J Leukoc Biol; 2020 Jul; 108(1):105-112. PubMed ID: 32272499 [TBL] [Abstract][Full Text] [Related]
30. Localization of granule proteins in human eosinophil bone marrow progenitors. Egesten A; Calafat J; Weller PF; Knol EF; Janssen H; Walz TM; Olsson I Int Arch Allergy Immunol; 1997 Oct; 114(2):130-8. PubMed ID: 9338606 [TBL] [Abstract][Full Text] [Related]
31. Formation of Charcot-Leyden crystals by human basophils. Ackerman SJ; Weil GJ; Gleich GJ J Exp Med; 1982 Jun; 155(6):1597-609. PubMed ID: 7042896 [TBL] [Abstract][Full Text] [Related]
32. An ultrastructural analysis of tumor-promoting phorbol diester-induced degranulation of human basophils. Dvorak AM; Warner JA; Morgan E; Kissell-Rainville S; Lichtenstein LM; MacGlashan DW Am J Pathol; 1992 Dec; 141(6):1309-22. PubMed ID: 1466396 [TBL] [Abstract][Full Text] [Related]
33. Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. Boyce JA; Friend D; Matsumoto R; Austen KF; Owen WF J Exp Med; 1995 Jul; 182(1):49-57. PubMed ID: 7540656 [TBL] [Abstract][Full Text] [Related]
34. Differences between basophils and mast cells: failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells. Leiferman KM; Gleich GJ; Kephart GM; Haugen HS; Hisamatsu K; Proud D; Lichtenstein LM; Ackerman SJ J Immunol; 1986 Feb; 136(3):852-5. PubMed ID: 3510254 [TBL] [Abstract][Full Text] [Related]
35. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Leonidas DD; Elbert BL; Zhou Z; Leffler H; Ackerman SJ; Acharya KR Structure; 1995 Dec; 3(12):1379-93. PubMed ID: 8747464 [TBL] [Abstract][Full Text] [Related]
36. Degranulation patterns of eosinophils in advanced gastric carcinoma: an electron microscopic study. Caruso RA; Ieni A; Fedele F; ZuccalĂ V; Riccardo M; Parisi E; Parisi A Ultrastruct Pathol; 2005; 29(1):29-36. PubMed ID: 15931778 [TBL] [Abstract][Full Text] [Related]
37. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Weller PF; Goetzl EJ; Austen KF Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7440-3. PubMed ID: 6261258 [TBL] [Abstract][Full Text] [Related]
38. F-met peptide-induced degranulation of human basophils. Dvorak AM; Warner JA; Kissell S; Lichtenstein LM; MacGlashan DW Lab Invest; 1991 Feb; 64(2):234-53. PubMed ID: 1705302 [TBL] [Abstract][Full Text] [Related]
39. Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. Melo RC; Perez SA; Spencer LA; Dvorak AM; Weller PF Traffic; 2005 Oct; 6(10):866-79. PubMed ID: 16138901 [TBL] [Abstract][Full Text] [Related]
40. Eosinophil Charcot-Leyden crystal protein binds to beta-galactoside sugars. Dyer KD; Rosenberg HF Life Sci; 1996; 58(23):2073-82. PubMed ID: 8649192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]